AI-powered drug discovery captures pharma interest
E Smalley - Nature Biotechnology, 2017 - go.gale.com
A drug-hunting deal inked last month, between Numerate, of San Bruno, California, and
Takeda Pharmaceutical to use Numerate's artificial intelligence (AI) suite to discover small …
Takeda Pharmaceutical to use Numerate's artificial intelligence (AI) suite to discover small …
A study on the application and use of artificial intelligence to support drug development
MJ Lamberti, M Wilkinson, BA Donzanti… - Clinical …, 2019 - Elsevier
Abstract Purpose The Tufts Center for the Study of Drug Development (CSDD) and the Drug
Information Association (DIA) in collaboration with 8 pharmaceutical and biotechnology …
Information Association (DIA) in collaboration with 8 pharmaceutical and biotechnology …
[HTML][HTML] Artificial intelligence (AI) in pharmacy: an overview of innovations
MA Raza, S Aziz, M Noreen, A Saeed… - INNOVATIONS in …, 2022 - ncbi.nlm.nih.gov
Artificial Intelligence (AI) emerged as an intervention for data and number-related problems.
This breakthrough has led to several technological advancements in virtually all fields from …
This breakthrough has led to several technological advancements in virtually all fields from …
Computer-aided drug design and drug discovery: a prospective analysis
In the dynamic landscape of drug discovery, Computer-Aided Drug Design (CADD) emerges
as a transformative force, bridging the realms of biology and technology. This paper …
as a transformative force, bridging the realms of biology and technology. This paper …
Inside the nascent industry of AI-designed drugs
A IT - Nature medicine, 2023 - nature.com
Drug discovery is expensive, ineffi-cient, and fraught with failure. An estimated 86% of drug
candidates developed between 2000 and 2015 did not meet their stated endpoints. Despite …
candidates developed between 2000 and 2015 did not meet their stated endpoints. Despite …
AI on drugs: Can artificial intelligence accelerate drug development? Evidence from a large-scale examination of bio-pharma firms
Advances in artificial intelligence (AI) could potentially reduce the complexities and costs in
drug discovery. Using a resource-based view, we conceptualize an AI innovation capability …
drug discovery. Using a resource-based view, we conceptualize an AI innovation capability …
Artificial intelligence and personalized medicine
NJ Schork - Precision medicine in Cancer therapy, 2019 - Springer
The development of high-throughput, data-intensive biomedical research assays and
technologies has created a need for researchers to develop strategies for analyzing …
technologies has created a need for researchers to develop strategies for analyzing …